Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United StatesFood, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
Holland & Knight Health Dose is an in-depth weekly
dose of legislative and regulatory insights to keep stakeholders
abreast of happenings in Washington, D.C., impacting the health
sector.
This week's topics include:
PAHPA Reauthorization RFI: Responses Due in Two Weeks
Capitol Hill's Push for PBM Reform
DEA Releases Proposed Rule to Scale Back COVID-Era Telehealth
Policies
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
